Singular Genomics Systems, Inc. (NASDAQ:OMIC - Get Free Report)'s stock price traded up 0.4% during mid-day trading on Tuesday . The stock traded as high as $23.00 and last traded at $22.97. 6,086 shares changed hands during mid-day trading, a decline of 83% from the average session volume of 34,845 shares. The stock had previously closed at $22.88.
Singular Genomics Systems Stock Down 0.3 %
The company has a debt-to-equity ratio of 0.05, a current ratio of 8.77 and a quick ratio of 8.04. The stock has a 50-day moving average price of $14.66 and a 200-day moving average price of $11.17.
Singular Genomics Systems (NASDAQ:OMIC - Get Free Report) last announced its quarterly earnings results on Tuesday, November 12th. The company reported ($6.72) earnings per share (EPS) for the quarter, beating the consensus estimate of ($8.05) by $1.33. Singular Genomics Systems had a negative return on equity of 54.70% and a negative net margin of 3,237.89%. The business had revenue of $0.41 million during the quarter, compared to the consensus estimate of $0.74 million.
About Singular Genomics Systems
(
Get Free Report)
Singular Genomics Systems, Inc, a life science technology company, develops next generation sequencing and multiomics technology for researchers and clinicians to advance science and medicine. The company is involved in the developing of G4, consisting of G4 instrument and associated consumables for various applications, such as max read kits for single cell sequencing, rare variant detection with high-definition sequencing, gene fusion detection with ring-seq, and extended range sequencing; and PX instrument and associated consumables for applications comprising single cell gene expression and proteomics, in situ RNA sequencing, and spatial RNA and proteomics applications for tissue.
Recommended Stories
Before you consider Singular Genomics Systems, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Singular Genomics Systems wasn't on the list.
While Singular Genomics Systems currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
